Detalhe da pesquisa
1.
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
Am J Transplant
; 23(10): 1631-1640, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37778868
2.
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
MMWR Morb Mortal Wkly Rep
; 72(29): 793-801, 2023 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37471262
3.
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
MMWR Morb Mortal Wkly Rep
; 72(34): 920-925, 2023 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37616235
4.
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months - United States, April 2023.
MMWR Morb Mortal Wkly Rep
; 72(24): 657-662, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37319020
5.
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023.
MMWR Morb Mortal Wkly Rep
; 72(7): 177-182, 2023 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795625
6.
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.
MMWR Morb Mortal Wkly Rep
; 72(5): 119-124, 2023 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36730051
7.
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
MMWR Morb Mortal Wkly Rep
; 72(41): 1115-1122, 2023 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37824423
8.
Engagement With the Centers for Disease Control and Prevention Coronavirus Self-Checker and Guidance Provided to Users in the United States From March 23, 2020, to April 19, 2021: Thematic and Trend Analysis.
J Med Internet Res
; 25: e39054, 2023 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36745776
9.
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.
MMWR Morb Mortal Wkly Rep
; 71(45): 1436-1441, 2022 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36355612
10.
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years - United States, July 2022.
MMWR Morb Mortal Wkly Rep
; 71(31): 988-992, 2022 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35925807
11.
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.
MMWR Morb Mortal Wkly Rep
; 71(26): 859-868, 2022 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35771731
12.
Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons - 43 U.S. Jurisdictions, July 31-October 1, 2022.
MMWR Morb Mortal Wkly Rep
; 71(49): 1560-1564, 2022 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36480479
13.
Overview of the United States' Immunization Program.
J Infect Dis
; 224(12 Suppl 2): S443-S451, 2021 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590134
14.
The FDA Funding Crisis.
J Pharm Technol
; 30(2): 57-60, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34861005
15.
Safety and Effectiveness of Maternal COVID-19 Vaccines Among Pregnant People and Infants.
Obstet Gynecol Clin North Am
; 50(2): 279-297, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37149310
16.
An Evaluation of the Text Illness Monitoring (TIM) Platform for COVID-19: Cross-sectional Online Survey of Public Health Users.
JMIR Public Health Surveill
; 8(2): e32680, 2022 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34882572